查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602190

经皮贴片市场：按产品类型、技术、应用、分销管道和最终用户划分 - 全球预测 2025-2030

Transdermal Patches Market by Product, Type, Technology, Application, Distribution Channel, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年经皮贴片市场估值为85.7亿美元，预计到2024年将达到98.9亿美元，复合年增长率为16.40%，预计到2030年将达到248.4亿美元。

经皮贴片是一种黏性贴剂，可透过皮肤输送药物，确保药物在较长时间内稳定且受控地释放到血液中。它的非侵入性、改善的患者依从性以及绕过消化器官系统的能力使其对于吞嚥困难或需要特定药物的患者来说是不可或缺的。治疗范围从疼痛管理和尼古丁戒断到荷尔蒙补充疗法和慢性病治疗。最终用途主要包括医疗保健设施、诊所和居家医疗环境。经皮贴剂市场的成长主要是由慢性病的增加、经皮给药系统的采用增加以及贴片技术的进步所推动的。新的商机在于智慧技术的集成，例如用于剂量监测的感测器和针对特定患者需求的个人化医疗方法。公司可以从研发投资中受益，开发具有多种功能的贴片，例如不仅可以输送药物，还可以监测生命征象的贴片。其局限性包括皮肤刺激问题、某些药物的渗透性有限以及患者皮肤吸收的差异，这些都对疗效提出了挑战。此外，出于安全考虑，新经皮系统的监管核准可能会很严格，这可能会延迟产品上市。市场竞争非常激烈，主要企业都专注于产品组合扩张和地理影响力。创新机会存在于生物相容性材料的开发中，这些材料可以改善贴片黏附力并最大限度地减少皮肤反应，以及目前尚未广泛使用的生技药品的经皮给药选择。趋势包括转向混合系统，将经皮贴片和注射成分结合起来，以实现更全面的药物传递方法。由于技术进步和消费者偏好的变化，市场的性质正在发生动态变化，持续的创新和适应对于经皮贴片配方产业的持续成长和竞争优势至关重要。

主要市场统计
基准年[2023] 85.7亿美元
预测年份 [2024] 98.9亿美元
预测年份 [2030] 248.4亿美元
复合年增长率（%） 16.40%

市场动态：快速发展的经皮贴片市场的关键市场洞察

供需的动态交互作用正在改变经皮贴片市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地用于治疗慢性疾病的经皮贴片的兴起
    • 人们越来越偏好控制释放和非侵入性药物输送解决方案
    • 政府批准的经皮贴片数量增加
  • 市场限制因素
    • 与经皮贴片相关的高成本
  • 市场机会
    • 先进高效经皮给药贴片研发进展
    • 经皮贴片配方和製造的新进展
  • 市场挑战
    • 由于产品召回导致经皮製剂的局限性

波特的五力：驾驭经皮贴片市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解经皮贴片市场的外部影响

外部宏观环境因素在塑造经皮贴片市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解经皮贴片市场的竞争状况

对经皮贴片市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵式经皮贴片市场供应商绩效评估

FPNV定位矩阵是评估经皮贴片市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球越来越多地使用经皮贴片来治疗慢性疾病
      • 人们对受管制药物释放和非侵入性药物输送解决方案越来越感兴趣
      • 政府核准的经皮贴片数量增加
    • 抑制因素
      • 与经皮贴片相关的高成本
    • 机会
      • 持续研发先进、高效率的经皮给药贴剂
      • 经皮贴片配方和製造的新进展
    • 任务
      • 经皮药物的限制和产品召回
  • 市场区隔分析
    • 产品名称： 渗透力显着的多层药物贴片
    • 类型：尼古丁广泛需求经皮贴片
    • 技术：利用化学增强剂提高经皮吸收贴片的功效
    • 应用：扩大经皮贴片在荷尔蒙疗法的使用
    • 通路：经皮贴片在电商平台的普及
    • 最终使用者：医院经皮贴片处方增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章经皮贴片市场：副产品

  • 矩阵
  • 多层药物内黏剂
  • 水库
  • 单层含药黏剂

第七章经皮贴片市场：依类型

  • Buprenornhine经皮吸收贴片
  • 可乐定经皮吸收贴片
  • Fentanyl经皮吸收贴片
  • 尼古丁经皮吸收贴片
  • 奥昔布宁经皮吸收贴片

第八章经皮贴片市场：依技术分类

  • 化学强化剂
  • 目前的
  • 机械阵列
  • 热消融

第九章经皮贴片市场：依应用分类

  • 荷尔蒙疗法
  • 膀胱过动症
  • 缓解疼痛
  • 减少吸烟和戒烟支持

第10章经皮贴片市场：依通路划分

  • 离线
  • 在线的

第十一章经皮贴片市场：依最终用户分类

  • 诊所
  • 家庭护理设置
  • 医院

第十二章美洲经皮贴片市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太经皮贴片市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东和非洲经皮贴片市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • DifGen Pharmaceuticals 在美国製造地推出了第二款产品 Aveva 药物输送系统，这是一种Buprenornhine经皮系统。扩大我们的美国製造经皮贴片和舌下膜的製造和分销产品组合。
    • 绿叶製药在英国推出阿兹海默症新疗法
    • Corsair Pharma 宣布提供 2,300 万美元 B 系列资金筹措，以推进肺动脉高压临床试验
    • Vaxess 融资 900 万美元加速 mRNA 疫苗贴片的开发
    • Almirall 以 4500 万欧元获得西班牙阿兹海默症治疗药物的营销权
    • Corium 与 Lotus Pharmaceuticals 签署创新阿兹海默症治疗药物「ADLARITY」在多个亚洲市场的独家授权合约
    • Dexmedetomidine经皮吸收贴片突然核准用于术后疼痛管理
    • LTS 透过收购 Sorel 的可穿戴注射设备业务完成聚合物药物传输领域
    • BioNxt 帕金森氏症药物rotigotine经皮吸收贴片获得欧洲临床试验核准
    • Bioxt 签署治疗帕金森氏症的rotigotine经皮吸收贴片临床试验协议，并开始生产临床样品
    • LTS Roman主导投资专门从事无针分娩的公司
    • 收购 Tesa Labtec GmbH 是 AdhexPharma 发展的基石

公司名单

  • Novartis AG
  • Luye Pharma Group Ltd
  • Gedeon Richter Plc
  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • DifGen Pharmaceuticals LLC
  • Zydus Group
  • Bliss GVS Pharma Ltd.
  • Sparsha Pharma International Pvt Ltd
  • GlaxoSmithKline Plc
  • LAVIPHARM GROUP HOLDING SA
  • Purdue Pharma LP
  • Nitto Denko Corporation
  • UCB SA
  • Corsair Pharma, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Tesa SE by Beiersdorf AG
  • Medherant Limited
  • ALVOGEN
  • AdhexPharma SAS
  • Tapemark by LTS Lohmann Therapie-Systeme AG
  • Icure Pharmaceutical Inc.
  • ProSolus, Inc.
  • Corium, Inc.
  • Viatris Inc.
  • Boehringer Ingelheim International GmbH
  • Endo International plc
  • BioNxt Solutions Inc.
  • Bayer AG
  • Nutriband Inc
  • Teikoku Seiyaku Co., Ltd.
  • Perrigo Company plc
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
Product Code: MRR-FD3F12D540F6

The Transdermal Patches Market was valued at USD 8.57 billion in 2023, expected to reach USD 9.89 billion in 2024, and is projected to grow at a CAGR of 16.40%, to USD 24.84 billion by 2030.

Transdermal patches are adhesive patches that deliver medication through the skin, ensuring steady and controlled release into the bloodstream over time. They are essential due to their non-invasive nature, improved patient compliance, and ability to bypass the gastrointestinal system, which makes them suitable for patients with swallowing difficulties or specific medication requirements. Applications span from pain management and nicotine withdrawal to hormone replacement therapy and chronic disease treatment. The end-use scope primarily includes healthcare facilities, clinics, and home healthcare settings. Growth in the transdermal patch market is primarily driven by rising chronic disease prevalence, increasing adoption of transdermal drug delivery systems, and advancements in patch technology. Emerging opportunities lie in the integration of smart technologies like sensors for dosage monitoring and personalized medicine approaches targeting specific patient needs. Companies might benefit from investing in R&D for developing patches with multifunctional capabilities, such as patches that not only deliver medication but also monitor vital signs. Limitations include skin irritation issues, limited permeability to certain drugs, and variability in skin absorption among patients, which pose challenges to efficacy. Furthermore, regulatory approval for new transdermal systems is stringent due to safety concerns, potentially slowing down product launches. The market is highly competitive, with key players focusing on expanding portfolios and geographical presence. Innovation opportunities exist in biocompatible materials to improve patch adhesion and minimize skin reactions, and developing transdermal delivery options for biologics, which are currently underrepresented. Trends show a shift towards hybrid systems that combine transdermal patches with injectable components for a more comprehensive drug delivery method. The market's nature is dynamic, driven by technological advancements and evolving consumer preferences, making ongoing innovation and adaptation crucial for sustained growth and competitive advantage in the transdermal patch industry.

KEY MARKET STATISTICS
Base Year [2023] USD 8.57 billion
Estimated Year [2024] USD 9.89 billion
Forecast Year [2030] USD 24.84 billion
CAGR (%) 16.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transdermal Patches Market

The Transdermal Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased use of transdermal patches to treat chronic conditions worldwide
    • Rising preference for controlled drug release and non-invasive drug delivery solutions
    • Growing number of government approvals for transdermal patches
  • Market Restraints
    • High costs associated with transdermal patches
  • Market Opportunities
    • Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
    • Emerging advances in the formulation and manufacturing of transdermal patches
  • Market Challenges
    • Limitations associated with transdermal drugs along with product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Transdermal Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transdermal Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transdermal Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transdermal Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transdermal Patches Market

A detailed market share analysis in the Transdermal Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transdermal Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transdermal Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include Novartis AG, Luye Pharma Group Ltd, Gedeon Richter Plc, Johnson & Johnson Services, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., DifGen Pharmaceuticals LLC, Zydus Group, Bliss GVS Pharma Ltd., Sparsha Pharma International Pvt Ltd, GlaxoSmithKline Plc, LAVIPHARM GROUP HOLDING S.A., Purdue Pharma L.P., Nitto Denko Corporation, UCB S.A., Corsair Pharma, Inc., Amneal Pharmaceuticals, Inc., Tesa SE by Beiersdorf AG, Medherant Limited, ALVOGEN, AdhexPharma SAS, Tapemark by LTS Lohmann Therapie-Systeme AG, Icure Pharmaceutical Inc., ProSolus, Inc., Corium, Inc., Viatris Inc., Boehringer Ingelheim International GmbH, Endo International plc, BioNxt Solutions Inc., Bayer AG, Nutriband Inc, Teikoku Seiyaku Co., Ltd., Perrigo Company plc, and Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc..

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Matrix, Multi-layer Drug-in-Adhesive, Reservoir, and Single-layer Drug-in-Adhesive.
  • Based on Type, market is studied across Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, and Oxybutynin Transdermal Patch.
  • Based on Technology, market is studied across Chemical Enhancers, Electric Current, Mechanical Arrays, and Thermal Ablation.
  • Based on Application, market is studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction & Cessation Aid.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End Users, market is studied across Clinics, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
      • 5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
      • 5.1.1.3. Growing number of government approvals for transdermal patches
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with transdermal patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
      • 5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with transdermal drugs along with product recalls
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
    • 5.2.2. Type: Extensive requirement for nicotine transdermal patches
    • 5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
    • 5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
    • 5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
    • 5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transdermal Patches Market, by Product

  • 6.1. Introduction
  • 6.2. Matrix
  • 6.3. Multi-layer Drug-in-Adhesive
  • 6.4. Reservoir
  • 6.5. Single-layer Drug-in-Adhesive

7. Transdermal Patches Market, by Type

  • 7.1. Introduction
  • 7.2. Buprenorphine Transdermal Patch
  • 7.3. Clonidine Transdermal Patch
  • 7.4. Fentanyl Transdermal Patch
  • 7.5. Nicotine Transdermal Patch
  • 7.6. Oxybutynin Transdermal Patch

8. Transdermal Patches Market, by Technology

  • 8.1. Introduction
  • 8.2. Chemical Enhancers
  • 8.3. Electric Current
  • 8.4. Mechanical Arrays
  • 8.5. Thermal Ablation

9. Transdermal Patches Market, by Application

  • 9.1. Introduction
  • 9.2. Hormonal Therapy
  • 9.3. Overactive Bladder
  • 9.4. Pain Relief
  • 9.5. Smoking Reduction & Cessation Aid

10. Transdermal Patches Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Transdermal Patches Market, by End Users

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Home Care Settings
  • 11.4. Hospitals

12. Americas Transdermal Patches Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Transdermal Patches Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Transdermal Patches Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
    • 15.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
    • 15.3.3. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
    • 15.3.4. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
    • 15.3.5. Almirall Acquires Rights To Distribute Alzheimer's Treatment In Spain For An Initial EUR 45 Million
    • 15.3.6. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
    • 15.3.7. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
    • 15.3.8. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
    • 15.3.9. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.10. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.11. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
    • 15.3.12. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma's Growth Path

Companies Mentioned

  • 1. Novartis AG
  • 2. Luye Pharma Group Ltd
  • 3. Gedeon Richter Plc
  • 4. Johnson & Johnson Services, Inc.
  • 5. AbbVie Inc.
  • 6. Teva Pharmaceutical Industries Ltd.
  • 7. DifGen Pharmaceuticals LLC
  • 8. Zydus Group
  • 9. Bliss GVS Pharma Ltd.
  • 10. Sparsha Pharma International Pvt Ltd
  • 11. GlaxoSmithKline Plc
  • 12. LAVIPHARM GROUP HOLDING S.A.
  • 13. Purdue Pharma L.P.
  • 14. Nitto Denko Corporation
  • 15. UCB S.A.
  • 16. Corsair Pharma, Inc.
  • 17. Amneal Pharmaceuticals, Inc.
  • 18. Tesa SE by Beiersdorf AG
  • 19. Medherant Limited
  • 20. ALVOGEN
  • 21. AdhexPharma SAS
  • 22. Tapemark by LTS Lohmann Therapie-Systeme AG
  • 23. Icure Pharmaceutical Inc.
  • 24. ProSolus, Inc.
  • 25. Corium, Inc.
  • 26. Viatris Inc.
  • 27. Boehringer Ingelheim International GmbH
  • 28. Endo International plc
  • 29. BioNxt Solutions Inc.
  • 30. Bayer AG
  • 31. Nutriband Inc
  • 32. Teikoku Seiyaku Co., Ltd.
  • 33. Perrigo Company plc
  • 34. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.

LIST OF FIGURES

  • FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 285. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023